Waiting for weight loss and Contrave

woman with blue face Are you getting blue in the face waiting for a new prescription weight loss drug? Today may be your day. The expert advisory committee of the FDA (Endocrine and Metabolic) recommended that the FDA approve Contrave.

Since the FDA usually follows the advisory committee recommendations and especially because Contrave is a combination of two FDA approved medicines (bupropion and naltrexone) it would be difficult to concieve anything other than approval.

Weight loss is particularly topical in the US and millions of Americans are overweight--something that puts them at risk for diabetes and heart disease and all of the complications. Time of course will tell.  

Approval Date: 
Mon, 01/31/2011
Company: 
Orexigen

This website is not intended as medical advice, and you should consult your doctor before changing or adding any medicines or vitamins to those you may now be taking and about applying any strategies BEFORE you adopt any approach in this report. While diligent care has been taken to ensure the accuracy of the information provided during the preparation of this edition, no claim is made that all known actions, uses or side effects, strategies for cost containment, targets or cholesterol pathways are included in this report. The accuracy and currentness of information are ever subject to change relative to new guidelines, new information derived from drug research, development and general usage.